Nonalcoholic steatohepatitis (NASH) prevalence is rising with no pharmacotherapy approved. A major hurdle in NASH drug development is the poor translatability of preclinical studies to safe/effective clinical outcomes, and recent failures highlight a need to identify new targetable pathways. Dysr...
TMT-Based quantitative proteomic analysis reveals the key role of metabolic process, cell proliferation and apoptosis in intestine regeneration of Apostichopus japonicus
